Korean Journal of Veterinary Service (한국동물위생학회지)

The Korean Society of Veterinary Service (한국동물위생학회)
권호 표지

Functional and morphological changes of the livers by 5-fluorouracil treatment on diethylnitrosamine-treated rat

발암제 (DEN) 투여 rat의 간암 진행상태의 기능학적 및 형태학적 변화와 항암제(5-FU) 처리효과 시험

  • Kim Cheol-Ho (Northern branch of Gyeongnam Livestock Promotion Research Institute) ;
  • Cheon Sung-Hwa (Northern branch of Gyeongnam Livestock Promotion Research Institute) ;
  • Bhak Jong-Sik (Northern branch of Gyeongnam Livestock Promotion Research Institute) ;
  • Kim Nam-Cheol (Northern branch of Gyeongnam Livestock Promotion Research Institute) ;
  • Kang Chung-Boo (College of Veterinary Medicine, Gyeongsang National University)
  • 김철호 (경상남도 축산진흥연구소북부지소) ;
  • 천성화 (경상남도 축산진흥연구소북부지소) ;
  • 박종식 (경상남도 축산진흥연구소북부지소) ;
  • 김남철 (경상남도 축산진흥연구소북부지소) ;
  • 강정부 (경상대학교 수의과대학)
  • Published : 2006.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study is concerned with assessment of diethylnitrosamine (DEN 0.01 %) induced liver cell carcinogenesis by measurement of changes preceding the development of neoplasms. Therefore, it was undertaken to investigate changes of liver-specific enzyme activities in Sprague-Dawley (SD) rats by ad libitum feeding of DEN. And also. the changes of hepatic morphology in SD rats were detected by haematoxylineosin stain and immunohistochemistry (PCNA). 5- Fluorouracil (5- FU) is one of the most widely used anticancer agents for digestive cancers including hepatocellular carcinoma, and is known to affect the cell cycle and induce apoptosis of cancer cells. In the present study, SD rats were given drinking water containing 0.01% diethylnitrosamine (DEN) for 8 weeks. Minor behavioral change, brittleness of hair and decreased amount of water and diet intake were observed in rats 4 weeks after DEN administration. The body and liver weights were significantly (p < 0.05) decreased in rats 11 weeks after DEN administration. The liver weight ratio to body weight was rather stable and not significantly decreased in the all treatment groups. The liver specific enzyme activities (AST, ALT, ${\gamma}$-GTP) were significantly increased in all treatment groups compared to control group (p < 0.05). Variable size of liver tumor and hepatomegaly were observed in rats treated with DEN after 10 weeks. Numerous vacuoles were seen on the midzonal and or peripheral areas of hepatic lobules. The large and polymorphological hepatocytes with eosinophilic cytoplasm or densely basophilic mitotic nucleoli were seen. Several proliferative small round cells were seen on vacuolated and necrotic areas in peripheral hepatic lobules or portal areas. PCNA-positive cells were seen on the vacuolated portal areas and peripheral areas of hepatic lobules in the areas of small round cells. We examined functional and morphological changes of livers by 5 - FU treatments on DEN -treated rat. The DEN -treated rats compared to 5 - FU -treated rats after DEN treatment for 8 weeks. The serum total protein and triglyceride were significantly (p < 0.05) decreased, and the liver enzyme activities of AST and ALT were significantly(p < 0.05) increased. After 8 weeks, in the non-5-FU -treated group, the size of liver tumor were varied and hepatomegaly were observed, hepatocellular vacuolization, necrosis and steatosis were observed on the midzonal and peripheral areas of hepatic lobules. The large and polymorphological hepatocytes were seen, the interlobular connective tissues were proliferated. PCNA positive cells were seen in the portal areas and peripheral areas of hepatic lobules in the non-5-FU-treated group. In hepatocytes, condensation of nuclear chromatin and vacuolization were observed, shape of the nuclei were irregular, the degraded nuclei and organelles were observed. The livers of rats in the 5 - FU treatment group were seen grossly brilliant, red-brown color, and the vacuolated and degenerated regions, hyperplastic nodules were not nearly observed. In the electron microscope, the cytoplasm of the hepatocytes contained a large number of mitochondria, rough endoplasmic reticulum, developed organelles surrounding nuclei. The above findings suggest that 5 - FU will be effective as anti -liver tumor drug.

Keywords

References

  1. Kang CB, Ha WS, Kim CK. 1999. Development of apoptosis model and bioimmune responses in experimental animal 1. Induction and indicator of apoptosis and hepatic tumorigenesis. Korean J Vet Clin Med 16 (1) : 100-107
  2. Kang CB, Kim CK. Song SH, et al, 2001. Study on mechanism of multistep hepatotumorigenesis in rat: Bioindices on hepatic tumorigenesis. Korean J Vet Res 41 (4) : 583- 589
  3. Ha WS, Kim CK, Song SH, et al. 2001. Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J Vet Sci 2(1) : 53-58
  4. Peto R, Gray R, Brantom P, Grasso P. 1991. Effects on 4080 rats of chronic ingestion of N -nitrosodiethylamine or N -nitrosodimethyl- amine: a detailed dose-response study. Cancer Res 51 (23 Pt 2) : 6415-6451
  5. Verna L, Whysner J, Williams GM. 1996. N-nitrosodiethylamine mechanistic data and risk assessment: bio-activation, DNA-adduct formation, mutagenicity, and tumor initiation. Phermscol Ther 71 (1-2) : 57-81 https://doi.org/10.1016/S0163-7258(96)90014-5
  6. Heidelberger C, Chaudhuri NK. Danneberg P, et al. 1957. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179 (4561) : 663-666 https://doi.org/10.1038/179663a0
  7. Midena E, Angeli CD, Valenti M, et al, 2000. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil, Br J Ophthalmol 84 (3) : 268-272 https://doi.org/10.1136/bjo.84.3.268
  8. Mizutani Y, Wada H, Yoshida O, et al. 2003. Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res 9 (4) : 1453-1460
  9. Tritscher AM, Clark GC, Sewall C, et al. 1995. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Carcinogenesis 16 (1) : 2807 - 2811 https://doi.org/10.1093/carcin/16.11.2807
  10. Mo B, Pater A. 2003. Apoptosis, 5 -fluorouracil sensitivity and expression of apoptotic proteins in a human ectocervical cell carcinogenesis model using different media. Eur J Pharmacol 467(1-3) : 15- 22 https://doi.org/10.1016/S0014-2999(03)01558-9
  11. Malet-Martino M, Martino R. 2002. Clinical studies of three oral prodrugs of 5 -fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 7 (4) : 288-323 https://doi.org/10.1634/theoncologist.7-4-288
  12. Matsusaka S, Yamasaki H, Kitayama Y, Okada T, Maeda S. 2003. Differential effects of two fluorouracil administration regimens for colorectal cancer. Oncol Rep 10 (1) : 109-113
  13. Roos G, Stenram U. 1997. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat. J Surg Oncol 65 (3) : 155-158 https://doi.org/10.1002/(SICI)1096-9098(199707)65:3<155::AID-JSO2>3.0.CO;2-5
  14. Berrada M, Yang Z, Lehnert S. 2002. Tumor treatment by sustained intra tumoral release of 5 - fluorouracil: effects of drug alone and in combined treatments. Int J Radiat Oncol Biol Phys 54 (5) : 1550-1557 https://doi.org/10.1016/S0360-3016(02)03740-9
  15. Ueno H, Okada S, Okusaka T, et al. 2002. Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma. Cancer Chemother Pharmacol 49 (2) : 155-160 https://doi.org/10.1007/s00280-001-0400-8
  16. Pitot HC, Sirica AE. 1980. The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 605(2) : 191-215
  17. Ito N, Imaida K, Hasegawa R, et al. 1989. Rapid bioassay methods for carcinogens and modifiers of hepato-carcinogenesis. Crit Rev Toxicol 19 (4) : 385-415 https://doi.org/10.3109/10408448909029328
  18. Kovalszky I, Szeberenyi S, Zalatnai A, et al. 1992. Modification of DENA -induced hepatocarcinogenesis by $CCl_{4}$ cirrhosis. Comparison of the marker enzyme patterns. Carcinogenesis 13 (5) : 773-778 https://doi.org/10.1093/carcin/13.5.773
  19. 김길수, 박준형. 1992. 사염화탄소에 의한 랫드의 간손상에 미치는 인진호추출물의 영향. 대한수의학회지 32(3) : 347-356
  20. 김길수, 박준형. 1994. 사염화탄소에 의한 랫드의 간손상에 대한 인진호메타놀추출물의 억제효과. 대한수의학회지 34(3) : 619-629
  21. 강정부, 이은석, 허주형. 1997. 사염화탄소(($CCl_{4}$)의 투여가 쥐의 간 기능에 미치는 영향. 1. 임상증상 및 혈액화학치. 한국임상수의학회지14(2) : 268-272
  22. 강정부, 이은석, 허주형. 1997. 사염화탄소($CCl_{4}$)의 투여가 쥐의 간 기능에 미치는 영향. 2. 혈청 효소 활성치. 한국임상수의학회지 14(2) : 273-278
  23. 강정부, 손호상, 김철호. 1998. 2,2-Azobis (2-amidinopropane) Dihydrochloride (AAPH) 의 투여가 쥐의 간기능에 미치는 영향. 1. 임상증상 및 혈액 화학치 소견. 한국임상수의학회지 15(1) : 75-78
  24. 지관자. 1991. Diethylnitrosamine에 의한 흰쥐 간세포에 유전적 변화에 관한 연구. 인하대학교 대학원 박사학위 논문
  25. Tamano S, Merlino GT, Ward JM. 1994. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethvlamine and promoted by phenobarbital. Carcinogenesis 15 (9): 1791-1798 https://doi.org/10.1093/carcin/15.9.1791
  26. 곽수동, 강정부, 하우송. 1998. Diethyl-nitrosamine을 투여한 rat 간장의 tumorigenesis에 관하여. 1. 간장의 육안적 소견. 대한수의학회지 38(2) : 379-385
  27. Zafiriou G, Grekou A, Stravoravdi P, et al. 2002. Histological and ultrastructural study of the effect of chemotherapy with 5-fluorouracil on normal liver of Wistar rats. Chemotherapy 48 (6) : 298-302 https://doi.org/10.1159/000069711
  28. Dunsford HA, Karnasuta C, Hunt JM, et al. 1989. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 49(17) : 4894-4900
  29. Mathews MB, Bernstein RM, Franza BR Jr, et al. 1984. Identity of the proliferating cell nuclear antigen and cyclin. Nature 309 (5966) : 374-376 https://doi.org/10.1038/309374a0
  30. Hall PA, Levison DA. 1990. Review: assessment of cell proliferation in histological material. J Clin Pathol 43(3) : 184-192 https://doi.org/10.1136/jcp.43.3.184
  31. Waseem NH, Lane DP. 1990. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96 (Pt 1) : 121-129
  32. Deugnier YM, Charalambous P. 1993. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis a study of 185 patients. Hepatology 18 (6) : 1363-1369
  33. Adachi E, Hashimoto H, Tsuneyoshi M. 1993. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer 72(10) 2902-2909